upadacitinib

C-reactive protein ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35141743 Number Needed to Treat and Cost Per Responder of Janus Kinase Inhibitors Approved for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Japan. 2022 Feb 10 1
2 35142908 Relative remission rates of Janus kinase inhibitors in comparison with adalimumab in patients with active rheumatoid arthritis: a network meta-analysis. 2022 Feb 10 1
3 33053283 Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. 2020 Oct 15 1